NCT00642135View on ClinicalTrials.gov

CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment

PHASE3TerminatedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

June 30, 2008

Conditions
Retinal AnomaliesPremature Birth
Interventions
DRUG

Mydriasert®

Premature newborns and neonates treated using ophthalmologic insert Mydriasert®

DRUG

phenylephrine and tropicamide eyedrops

Premature newborns and neonates treated using reference treatment (association of Phenylephrine and tropicamide eyedrops)

Trial Locations (1)

75019

Hôpital Robert Debré, Paris

Sponsors

Collaborators (1)

Ioltech
All Listed Sponsors
collaborator

Ioltech

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT00642135 - CLAIR -FO: Clinical Trial of Ophthalmic Insert Mydriasert® Versus Reference Treatment | Biotech Hunter | Biotech Hunter